|Videos|October 12, 2021

Addressing Influenza in the COVID-19 Era

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

A group of experts led by Tina Q. Tan, MD, FAAP, FIDSA, FDIPS, discuss how best to address influenza prevention, identification, and treatment in the COVID-19 era and beyond.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Addressing Influenza in the COVID-19 Era

Related Content

Practice size: How many doctors are in the office?

Maternal mortality; brain implant research; $30M in phony claims for COVID-19 tests – Morning Medical Update

More than 90% of docs feeling burned out: survey

Doctors must have robust online presence to meet today’s patients’ expectations

Responding to patient requests for a second opinion

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

A hospital tried to replace them. These Oregon physicians fought back — and won

Young adults are slipping away from primary care, and they aren't the only ones

'A system of work': The tech that could keep practices independent

The future of Alzheimer's detection: How blood-based testing is reshaping screening, diagnosis and care

A biological clock that speeds up aging; RFK Jr. revives the Presidential Fitness Test; spring break, the deadliest drive — Morning Medical Update